Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.

Gastroenterology | Apr 29, 2011

http://www.ncbi.nlm.nih.gov/pubmed/21237170

BACKGROUND & AIMS: Studies of hepatitis C virus (HCV) infection, immunopathogenesis, and resulting liver diseases have been hampered by the lack of a small animal model. We developed humanized mice with human immune system and liver tissues to improve the studies of hepatitis C virus pathogenesis and treatment. METHODS: To promote engraftment of human hepatocytes, we expressed a fusion protein of the FK506 binding protein (FKBP) and caspase 8 under control of the albumin promoter (AFC8), which induces liver cell death, in Balb/C Rag2(-/-) γC-null mice. Cotransplantation of human CD34(+) human hematopoietic stem cells (HSC) and hepatocyte progenitors into the transgenic mice led to efficient engraftment of human leukocytes and hepatocytes. We then infected these humanized mice (AFC8-hu HSC/Hep) with primary HCV isolates and studied HCV-induced immune responses and liver diseases. RESULTS: AFC8-hu HSC/Hep mice supported HCV infection in the liver and generated a human immune T-cell response against HCV. HCV infection induced liver inflammation, hepatitis, and fibrosis, which correlated with activation of stellate cells and expression of human fibrogenic genes. CONCLUSIONS: AFC8-hu HSC/Hep mice are a useful model of HCV infection, the immune response, and liver disease because they contain human immune system and liver cells. These mice become infected with HCV, generate a specific immune response against the virus, and develop liver diseases that include hepatitis and fibrosis. This model might also be used to develop therapeutics for HCV infection.

Pubmed ID: 21237170 RIS Download

Mesh terms: Animals | Caspase 8 | DNA-Binding Proteins | Disease Models, Animal | Female | Hepacivirus | Hepatitis C, Chronic | Hepatocytes | Humans | Liver Cirrhosis | Mice | Mice, Inbred BALB C | Mice, Transgenic | Stem Cells | Tacrolimus Binding Proteins | Transplantation, Heterologous

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIAAA NIH HHS, Id: AA018009
  • Agency: NIAAA NIH HHS, Id: AA018372
  • Agency: NIAID NIH HHS, Id: AI076142
  • Agency: NIAID NIH HHS, Id: AI077454
  • Agency: NIAID NIH HHS, Id: R01 AI077454
  • Agency: NIAID NIH HHS, Id: R01 AI077454-01A2
  • Agency: NIAID NIH HHS, Id: R01 AI080432
  • Agency: NIAID NIH HHS, Id: R01 AI080432-01A2
  • Agency: NIAID NIH HHS, Id: R01 AI095097
  • Agency: NIAAA NIH HHS, Id: R21 AA018009
  • Agency: NIAAA NIH HHS, Id: R21 AA018009-01
  • Agency: NIAAA NIH HHS, Id: R21 AA018009-02
  • Agency: NIAID NIH HHS, Id: R21 AI076142
  • Agency: NIAID NIH HHS, Id: R21 AI076142-01A1
  • Agency: NIAID NIH HHS, Id: R21 AI076142-02
  • Agency: NCRR NIH HHS, Id: RR024143
  • Agency: NIAID NIH HHS, Id: T32 AI007273

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.